SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-18-009303
Filing Date
2018-04-26
Accepted
2018-04-26 16:05:25
Documents
5
Period of Report
2018-06-07
Effectiveness Date
2018-04-26

Document Format Files

Seq Description Document Type Size
1 DEF14A PROXY STATEMENT kura-def14a_20180607.htm DEF 14A 780180
2 GRAPHIC g2018041820563024415741.jpg GRAPHIC 63364
3 GRAPHIC g2018041820563021515740.jpg GRAPHIC 72917
4 GRAPHIC g2018041820562232215738.jpg GRAPHIC 1984
5 GRAPHIC g2018041820563020415739.jpg GRAPHIC 2790
  Complete submission text file 0001564590-18-009303.txt   976230
Mailing Address 3033 SCIENCE PARK ROAD, SUITE 220 SAN DIEGO CA 92121
Business Address 3033 SCIENCE PARK ROAD, SUITE 220 SAN DIEGO CA 92121 (858) 500-8800
Kura Oncology, Inc. (Filer) CIK: 0001422143 (see all company filings)

IRS No.: 611547851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37620 | Film No.: 18778515
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences